Bullboard - Stock Discussion Forum Ibio Inc IBIO

Healthcare Biotechnology

iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. The Company develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu... see more

Add To Watchlist

NYSEAM:IBIO - Post Discussion

Ibio Inc > CEO Tom Isett talks TODAY at 3:30 - $iBio

View:

Post by FelixFun on Jul 30, 2020 9:52am

CEO Tom Isett talks TODAY at 3:30 - $iBio

"Look forward to discussing what’s possible in massive plant-based #vaccine manufacturing and its two vaccine candidates with #iBio CEO Tom Isett on today’s #coronavirus report"

Company Overview
iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform.
The iBio Technology platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines.

#iBio $iBio iBio

257